Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for the adjuvant treatment of patients with melanoma with BRAF V600E...
Read MoreCynosure are proud to announce a host of upcoming educational and commercial activities at the FACE Conference, London (14-16th June 2018). The main activity will be an exclusive commercial workshop (more…)
Read MoreSciton®, a leading manufacturer of high-quality laser and light systems in the aesthetic medical market, is pleased to announce a new leadership team that will propel the company forward. This...
Read MoreDr Frédéric Flament, Global Head of instrumental Science, L’Oréal, will be giving a keynote presentation on Skin Ageing at the upcoming 3rd International Skin Care Conference in Bangkok, Thailand. During...
Read MoreAptos is happy to announce the competition for writing an article on Aptos methods. The article should be unique and not published earlier. The work will be evaluated by the...
Read MoreThe BACN were delighted to achieve an array of awards at the MyFaceMyBody Awards 2018 which took place on March 17 at the Royal Garden Hotel in Kensington. Celebrating innovation and customer excellence within this fast-growing...
Read MoreDue to the overwhelming demand following the record sell-out of places on the first OFAA for BACN cadaver training course, created specifically for the BACN, which ran on the 17th...
Read MoreThe Great British Academy of Aesthetic Medicine, a leading British academy focused on raising standards of training in aesthetic medicine, announced that they would be hosting a premiere Aesthetic Medicine...
Read More